查詢結果分析
相關文獻
- Penicillin-Nonsusceptible Streptococcus Pneumoniae Infections in Children
- 盤尼西林抗藥性肺炎雙球菌感染
- 臺灣地區抗藥性肺炎雙球菌的分子流行病學
- Prevalence of Penicillin-Resistant Streptococcus Pneumoniae at a Medical Center in Taipei
- Pneumococcal Infection in Children: Rational Antibiotic Choice for Drug-Resistant Streptococcus pneumoniae
- 對penicillin有抗藥性的肺炎雙球菌感染症
- 盤尼西林抗藥性肺炎雙球菌
- 肺炎雙球菌及其抗藥性
- Antimicrobial Resistance and Serotype Distribution of Streptococcus Penumoniae Strains Isolated in Southern Taiwan
- Drug Resistance Patterns of Tuberculosis in Taiwan
頁籤選單縮合
| 題 名 | Pneumococcal Infection in Children: Rational Antibiotic Choice for Drug-Resistant Streptococcus pneumoniae=兒童時期的肺炎雙球菌感染:對具抗藥性細菌的合理抗生素治療 |
|---|---|
| 作 者 | 邱貞嘉; 謝凱生; | 書刊名 | 臺灣兒科醫學會雜誌 |
| 卷 期 | 44:2 民92.03-04 |
| 頁 次 | 頁67-74+119 |
| 分類號 | 417.5351 |
| 關鍵詞 | 肺炎雙球菌; 抗藥性; Streptococcus pneumoniae; Rsistance; |
| 語 文 | 英文(English) |
| 中文摘要 | 肺炎雙球菌是引起兒童時期肺炎、中耳炎、鼻竇炎及腦膜炎的重要細菌。在過去十年肺炎雙球菌的抗藥性節節上昇。台灣地區的抗藥性比例更是幾近全球之冠。引起抗藥性的機轉主要是盤尼西林攜帶蛋白(penicillin-binding protein/簡稱PBP)的改變,因此使用β-lactamase抑制劑並無法克服抗藥性的問題。欲治療肺炎雙球菌感染,必需依(1)感染部位(2)抗藥性的程度來選擇用藥;且現今抗藥性標准分爲二套,即中樞神經感染及非中樞神經感染。一般而言對非中樞神經,susceptible或intermediate之肺炎雙球菌感染,盤尼西林仍具有優良殺菌效果。Vancomycin並不該在所有情況皆做爲第一線用藥。 |
| 英文摘要 | Streptococcus pneumoniae is one of the most common bacterial causes of otitis media, sinusitis, bacteremia, pneumonia and bacterial meningitis in the pediatric population. The resistance of S. pneumoniae to penicillin and other antimicrobial agents is increasing in many parts of the world. In Taiwan, extremely high prevalence (70%) of penicillin-resistant S. pneumoniae among children with nasopharyngeal carriage has been reported. The mechanism of resistance to penicillin is the alteration of penicillin binding protein (PBP) instead of the production of β-lactamase. Thus β-lactamase inhibitors are not the solution to the treatment of infections caused by penicillin-resistant S. pneumoniae. The adequate treatment of infections caused by penicillin-resistant S. pneumoniae should be based on (1) site of infection (2) degree of resistance. Currently, the MIC breakpoints for S. pneumoniae are divided to 2 categories; one for CNS infection and the other for non-CNS infections. For non-CNS infections caused by susceptible or intermediate S. pneumoniae, penicillin still remains the drug of choice with excellent bactericidal activity. Vancomycin should not be the first choice in treating all pneumococcal infections. |
本系統中英文摘要資訊取自各篇刊載內容。